* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 8. 8. 8. PА а=Р/ Р Р
Survey
Document related concepts
Fetal origins hypothesis wikipedia , lookup
Epidemiology of measles wikipedia , lookup
Compartmental models in epidemiology wikipedia , lookup
Infection control wikipedia , lookup
Epidemiology wikipedia , lookup
Human mortality from H5N1 wikipedia , lookup
Influenza A virus subtype H5N1 wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Public health genomics wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Transmission and infection of H5N1 wikipedia , lookup
Viral phylodynamics wikipedia , lookup
Swine influenza wikipedia , lookup
Transcript
COMMUNICABLE DISEASE MANUAL POLICIES / PROCEDURES INFLUENZA SEASONAL & NOVEL INFLUENZA OBJECTIVE: Control and management of Influenza. DESCRIPTION: Influenza is an illness affecting the respiratory tract. Infections can result in severe complications. The incubation period for influenza is usually two (2) days, but can vary from one (1) to four (4) days after exposure. Symptoms include fever (often high), fatigue, headache, muscle pain, cough, runny nose, chills and sore throat. The illness can last several days. Influenza is spread via respiratory droplet infection. Systemic symptoms and temperature usually last from two (2) to three (3) days, rarely more than five (5) days. They may be decreased by such medications as aspirin or acetaminophen. Aspirin should not be used for infants, children, or teenagers, because they may be at risk for contracting Reye’s Syndrome following an influenza infection. Recovery is usually rapid, but some may have lingering depression and asthenia (lack of strength or energy) for several weeks. The most frequent complication of influenza is pneumonia, most commonly secondary bacterial pneumonia (e.g. Streptococcus pneumoniae, Haemophilus influenzae, or staphylococcus aureus). Primary Influenza viral pneumonia is an uncommon complication with a high fatality rate. Reye’s Syndrome is a complication that occurs almost exclusively in children taking aspirin, primarily in association with Influenza B (or varicella zoster), and presents with severe vomiting and confusion which may progress to coma, due to swelling of the brain. Other complications include myocarditis (inflammation of the heart), and worsening of chronic bronchitis and other chronic pulmonary diseases. Death is reported in 0.5-1 per 1000 cases. The majority of deaths occur in persons > 65 years of age. The risk for complications and hospitalizations from influenza are higher among persons 65 and older, young children, and persons of any age with certain medical conditions. Influenza A causes moderate to severe illness, and affects all age groups. The virus infects humans and other animals, such as pigs and birds. Influenza B generally causes milder disease than type A, and primarily affects children. It affects only humans. Influenza C is rarely reported as a cause of human illness, probably because most cases are subclinical. It has not been associated with epidemic disease. EQUIPMENT: D:\582763132.docPage 1 of 7 Michigan Disease Surveillance System (MDSS) User Manual (disease specific forms [Influenza-Seasonal and Novel Influenza] will be found in MDSS. The CDC Influenza-Associated Pediatric Deaths Case Report Form and MDCH policy is located in the Addendum section at the end of this policy. FAX “Notification of Serious Communicable Disease” to Michigan Department of Community Health (MDCH) if confirmed or suspected Novel Influenza case or Pediatric death. Also MDCH Web site at www.michigan.gov/mdch, www.michigan.gov/cdinfo and Centers for Disease Control (CDC) Web site at www.cdc.gov/diseasesconditions/az/a.html. POLICY: Legal Responsibility: Michigan's communicable disease rules of Act No. 368 of the Public Acts of 1978, as amended, being 333.5111 of the Michigan Compiled Laws. Follow-up time is within 24 hours of receiving referral. If suspected or confirmed Novel influenza or outbreak, notify MDCH by fax and CD Supervisor who will notify Medical Director, Health Officer and HD Emergency Manager. In absence of CD Supervisor, follow above established chain of command. PROCEDURE: A. Case Investigation D:\582763132.docPage 2 of 7 Influenza (Seasonal) 1. For reporting seasonal influenza (replacing the individual Flu-Like Disease form). 2. Referrals received per phone call, laboratory results, or automatically through MDSS. 3. Document all case investigation proceedings. 4. Contact MD and/or client to start process of completing disease specific form in MDSS within 24 hours of receipt of referral unless instructed to do differently by MDCH or CDC. 5. Purpose is to identify those influenza cases that are unusual in their timing, scope or severity (see description at top of form). This form is used in reporting of: a.) all influenza cases during May-September; b.) facility outbreak cases; c.) unusual or severe cases; d.) all influenza cases October-April. 6. Not to be used for Novel influenza strains (avian, pandemic or new human strains). Please use the Novel Influenza MDSS case form. 7. PDF form with first page similar to other MDSS forms. 8. All information fields should be filled out as completely as possible (except for optional contact information form on Page 4). 9. While MDCH is most interested in those types of cases listed at the top of the form, Local Health Departments (LHD’s) may also utilize this form to track all of their seasonal influenza cases from October-April, OR, add to weekly aggregate flu-like disease counts in MDSS. 10. As of December 14, 2006, the individual case report form for Flu-Like Disease SHOULD NOT BE USED. Cases with some sort of lab confirmation (culture, smear, rapid test, etc.) should now be reported as INFLUENZA. If a lab or health care provider enters a case into MDSS as FluLike Disease, the reportable condition will need to be changed to INFLUENZA before completing the case investigation. 11. Reporting of typical Seasonal Influenza lab confirmed cases from October-April required fields in MDSS are: 12. 13. D:\582763132.docPage 3 of 7 Part of an outbreak: Yes No Unknown Investigation status: Active Case status: Confirmed Patient status: Inpatient/Outpatient Patient status: Date of entry Diagnosis date: Date of lab result First name Last name NOTE: In the middle initial field, enter Influenza type “A” or “B”. Address, zip code, date of birth, sex, race/ethnicity NOTE: Parent’s name is required if case is less than 18 years of age. If parent’s first and last name is unavailable, type “Unknown/Unknown” or type the word “p-a-r-e-n-t/and the child’s last name” in place of parent’s actual first/last name. Laboratory name Town of laboratory Doctor’s first and last name Submitted by Date, Health Department, and Phone Number of nurse. Comments Section; No Further Follow-up Needed as Individual Count only. The status of the case investigation needs to be “Active” once completed for the Administrator to know to change status to “Complete”. These cases are not tallied on the MDSS Aggregate Case Report as this would be double counting, but are reported on the Monthly Communicable Disease Report. MDCH should be immediately notified of any possible influenza-associated pediatric deaths in patients less than 18 years of age. The CDC-specific form that must be completed for these cases is located in the Addendum at the end of this policy along with the MDCH policy. Also, complete the Influenza form on MDSS. Please fax the “Notification of Serious Communicable Disease” to MDCH and call at (517)335-8165. Novel Influenza B. D:\582763132.docPage 4 of 7 1. For reporting all human cases of avian influenza or a new human influenza strain (replacing the use of the Unusual Outbreak form for these cases). 2. Referrals received per phone call, laboratory results, or automatically through MDSS. 3. Document all case investigation proceedings. 4. Contact MD and/or client to start process of completing disease specific form in MDSS within 24 hours of receipt of referral, unless instructed to do differently by MDCH or CDC. 5. This form will be used to report initial cases in the event of an influenza pandemic; after a certain number of cases, MDCH will inform you to switch to aggregate counts. 6. All data fields should be completely filled out, including the contact form. This information will be critical to an investigation. 7. Any suspected and/or confirmed cases of any type of Novel influenza virus should be reported immediately to the MDCH Communicable Disease Division at (517)-3358165, or after-hours at (517)-335-9030. Also, FAX “Notification of Serious Communicable Disease” form to MDCH at (517)-335-8263. See “Pandemic Flu”, Policy/Procedure #7402 and “Avian Influenza”, Policy/Procedure #7406. 8. MDCH should be immediately notified of any possible influenza-associated pediatric deaths in patients less than 18 years old. The CDC-specific form that must be completed for these cases is located in the Addendum at the end of this policy along with the MDCH policy. Also, complete the Novel Influenza form on MDSS. Please fax the “Notification of Serious Communicable Disease” to MDCH and call at (517)-335-8165. Lab Diagnosis 1. MDCH is very interested in cases that are off-season, i.e. MaySeptember, as well as the first cases from each region or jurisdiction in the fall. Please try to report these cases and obtain clinical samples to be sent to the MDCH lab for viral culture confirmation. 2. Many healthcare providers are now using rapid influenza tests, which can test for Influenza A and/or B antibodies. However, these tests have a low positive predictive value when influenza is not circulating in the community. This means that there are many false positives in the summer and early fall, yet many clinicians appear to be basing their diagnoses on these tests. If you come across a case that has tested positive via a rapid test, and influenza is not being reported in your community, please consider immediately contacting the referrer to pursue culture confirmation. Samples from rapid tests are often immediately discarded, so time is of the essence. C. 3. Encourage healthcare providers and clinical labs in your jurisdiction to refrigerate and/or freeze samples after their testing is completed (see #4 below for more details). 4. Samples being sent to the MDCH lab for viral culture must be refrigerated and shipped on cold packs within 48 hours of collection. Over weekends and holidays, samples can be shipped after 48 hours of collection if they have been stored in a -70ºF freezer and shipped on dry ice. If shipping on dry ice, the package is considered dangerous goods, and there will be additional shipping requirements. 5. Be prepared to order influenza test kits from the MDCH lab at the first indication of an outbreak. 6. Please contact the MDCH Communicable Disease Division at (517)-335-8165 if you have any questions regarding reporting or case investigations. For information regarding influenza test kits, shipping or laboratory testing, please contact the MDCH laboratory at (517)-335-8063. Control Measures Part I 1. 2. Educate the public and health care personnel in basic personal hygiene, especially transmission via unprotected coughs and sneezes, and from hand to mucous membrane. The Flu Fact Sheet on Prevention of Flu and What to Do If You Become Sick are located in the Addendum section at the end of this policy. Part II D:\582763132.docPage 5 of 7 1. Vaccinate with Influenza Vaccine: There are two (2) types – inactivated (killed) vaccine given by injection and (live) Flu-Mist which is sprayed into the nostrils. Influenza season usually peaks in February, but it can peak any time from November through May, so getting a shot anytime from October through January can be beneficial. 2. Population needing flu vaccine: a. People 65 years of age and older. b. Residents of long term care facilities. c. People with long term health problems of heart disease, lung disease, kidney disease, asthma, diabetes, anemia, d. e. f. g. h. i. j. k. l. m. 3. D. E. D:\582763132.docPage 6 of 7 blood disorders, muscle or nerve disorders (seizure disorders or cerebral palsy). People with weakened immune system, i.e. HIV/AIDS, long term treatment with steroids or cancer treatment with x-ray or drugs. People 6 months to 18 years of age on long term aspirin treatment. Women who will be pregnant during flu season. All children 6-59 months of age. Household contacts and out of home caretakers of children. Healthcare workers People providing essential community service. People living in dormitories or crowded conditions. People 50 years of age or older. Anyone wanting to reduce their chance of getting influenza age 6 months and older. Most people need one flu shot each year. Children younger than nine (9) years of age getting influenza vaccine for the first time should get two (2) doses, given at least one (1) month apart. References 1. Michigan Communicable Disease Rules 2. Current Red Book 3. Current Control of Communicable Disease Manual Addendums 1. Algorithm for LHD reporting of Influenza – 10/07 MDCH 2. 3. Influenza outbreaks – suggested information to collect – 10/07 MDCH Routine Influenza Algorithm – MDCH Clinical Labs 4. Novel/Avian Influenza Algorithm – MDCH Clinical Labs 5. Case Detection and Clinical Management during the Interpandemic and Pandemic Alert Periods. 6. MDSS Policy: Influenza-Associated Pediatric Mortality. 7. 02-01-08 – Request by CDC for Bacterial Isolates from InfluenzaAssociated Pediatric Deaths with Staphylococcus aureus coinfection with Health Alert Network (HAN) Alert 01-20-08. 8. Guidance for Medical Examiners and Pathologists regarding Influenza-Related pediatric mortality. 9. CDC: Influenza-Associated Pediatric Deaths Case Report Form D:\582763132.docPage 7 of 7 10. MDCH Influenza Outbreak Guidelines for Long-Term Care Facilities – 10/2007 11. “Key Facts About The Flu” Fact Sheets